November 18, 2004 Intellectual Property Strategy and Best Practices in China and India Life Sciences Business Transactions This paper is based on a presentation made at the Asia America Multitechnology Association ("AAMA") Conference on October 8, 2004. Related Insights Experience Fenwick Represents Star Therapeutics in its Pending Sale of Vega Therapeutics to Incyte June 8, 2026 News Fenwick Earns Top Rankings in Chambers USA 2026 June 4, 2026 Experience Fenwick Represents CareDX in Pending Acquisition of Naveris April 27, 2026 Experience Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific April 14, 2026 Experience Fenwick Represents Day One Biopharmaceuticals in $2.5B Acquisition by Servier March 6, 2026 Experience Fenwick Represents Surf Bio in $400M Acquisition by Halozyme January 28, 2026 Experience Fenwick Represents Day One in $285 Million Acquisition of Mersana Therapeutics November 13, 2025 View more insights
Experience Fenwick Represents Star Therapeutics in its Pending Sale of Vega Therapeutics to Incyte June 8, 2026
Experience Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific April 14, 2026
Experience Fenwick Represents Day One Biopharmaceuticals in $2.5B Acquisition by Servier March 6, 2026
Experience Fenwick Represents Day One in $285 Million Acquisition of Mersana Therapeutics November 13, 2025